Skip to content
Screener

Interest Expense at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$93M-27.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$281M-8.8%
Staar Surgical logo
Staar SurgicalSTAA
$907K-33.6%
Ardelyx logo
ArdelyxARDX
$4.96M+13.8%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$7.2M-13.8%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$892K+0.1%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.21B+3.8%
Enterprise value$21.66B-2.1%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseDebt.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
3,4741,983
Operating (loss) income(950)276
Interest income1011
Interest expense(402)(330)
Loss on extinguishment of debt(1)
Foreign exchange and other(11)(4)
Loss before income taxes(1,354)(47)
Provision for income taxes(77)(39)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's interest expense?
Bausch Health Companies (BHC) reported interest expense of $402M in Q1 2026.
How has Bausch Health Companies's interest expense changed year-over-year?
Bausch Health Companies's interest expense increased by 21.8% year-over-year, from $330M to $402M.
What is the long-term trend for Bausch Health Companies's interest expense?
Over 4 years (2021 to 2025), Bausch Health Companies's interest expense has grown at a 3.0% compound annual growth rate (CAGR), from $1.43B to $1.6B.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ask your AI about Bausch Health Companies's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude